26868 Federal Register / Vol. 65, No. 90 / Tuesday, May 9, 2000 / Notices

If the institution filed a DS–2

submission, claimed allocation

methodology may be referenced to

specific section of DS–2.

[FR Doc. 00–11540 Filed 5–8–00; 8:45 am]

BILLING CODE 3110–01–P

SECURITIES AND EXCHANGE

COMMISSION

Sunshine Act Meeting

Notice is hereby given, pursuant to

the provisions of the Government in the

Sunshine Act, Pub. L. 94–409, that the

Securities and Exchange Commission

will hold the following meeting during

the week of May 8, 2000.

A closed meeting will be held on

Thursday, May 11, 2000 at 11 a.m.

Commissioners, Counsel to the

Commissioners, the Secretary of the

Commission, and recording secretaries

will attend the closed meeting. Certain

staff members who have an interest in

the matters may also be present.

The General Counsel of the

Commission, or his designee, has

certified that, in his opinion, one or

more of the exemptions set forth in 5

U.S.C. 552b(c)(4), (8), (9)(A) and (10),

permit consideration for the scheduled

matters at the closed meeting.

The subject matter of the closed

meeting scheduled Thursday, May 11,

2000 will be:

• Institution and settlement of

injunctive actions; and

• Institution and settlement of

administrative proceedings of an

enforcement nature.

At times, changes in Commission

priorities require alterations in the

scheduling of meeting items. For further

information and to ascertain what, if

any, matters have been added, deleted

or postponed, please contact:

The Office of the Secretary at (202)

942–7070.

Dated: May 5, 2000.

Jonathan G. Katz,

Secretary.

[FR Doc. 00–11668 Filed 5–5–00; 1:19 pm]

BILLING CODE 8010–01–M

SMALL BUSINESS ADMINISTRATION

Notice Seeking Exemption Under

Section 312 of the Small Business

Investment Act, Conflicts of Interest

Notice is hereby given that TD Javelin

Capital Fund, LP (‘‘TD Javelin’’), 2850

Cahaba Road, Suite 240, Birmingham,

Alabama 35223, a Federal Licensee

under the Small Business Investment

Act of 1958, as amended (‘‘the Act’’), TD

Javelin Capital Fund II, LP (‘‘TD Javelin

II’’), 2850 Cahaba Road, Suite 240,

Birmingham, Alabama 35223, a Federal

Licensee under the Act, and TD

Lighthouse Capital Fund, LP (‘‘TD

Lighthouse’’, and together with TD

Javelin and TD Javelin II, the ‘‘Funds’’),

303 Detroit Street, Suite 301, Ann

Arbor, Michigan 48104, an applicant for

a Federal license under the Act, in

connection with the financing of a small

concern, are seeking an exemption

under section 312 of the Act and section

107.730, Financings which Constitute

Conflicts of Interest of the Small

Business Administration (‘‘SBA’’) rules

and regulations (13 CFR 107.730

(2000)). The Funds propose to provide

equity financing to t-Breeders, Inc. (‘‘tBreeders’’), One Innovation Drive,

Worcester, Massachusetts 01605. The

financing is contemplated for product

development and working capital.

The financing is brought within the

purview of Sec. 107.730(a)(1) of the

Regulations because TD Javelin, an

Associate of the Funds, currently owns

greater than 10 percent of t-Breeders and

therefore t-Breeders is considered an

Associate of each of the Funds as

defined in Sec. 107.50 of the

regulations.

Notice is hereby given that any

interested person may submit written

comments on the transaction to the

Associate Administrator for Investment,

U.S. Small Business Administration,

409 Third Street, SW, Washington, DC

20416.

Dated: April 26, 2000.

Don A. Christensen,

Associate Administrator for Investment.

[FR Doc. 00–11496 Filed 5–8–00; 8:45 am]

BILLING CODE 8025–01–P

SMALL BUSINESS ADMINISTRATION

Notice Seeking Exemption Under

Section 312 of the Small Business

Investment Act, Conflicts of Interest

Notice is hereby given that TD Javelin

Capital Fund, LP (‘‘TD Javelin I’’), 2850

Cahaba Road, Suite 240, Birmingham,

Alabama 35223, a Federal Licensee

under the Small Business Investment

Act of 1958, as amended (‘‘the Act’’),

and TD Javelin Capital Fund II, LP (‘‘TD

Javelin II’’, and together with TD Javelin

I the ‘‘Funds’’), 2850 Cahaba Road, Suite

240, Birmingham, Alabama 35223, a

Federal Licensee under the Act, in

connection with the financing of a small

concern, have sought an exemption

under section 312 of the Act and section

107.730, Financings which Constitute

Conflicts of Interest of the Small

Business Administration (‘‘SBA’’) rules

and regulations (13 CFR 107.730

(2000)). The Funds propose to provide

equity financing to Prolinx, Inc.

(‘‘Prolinx’’), 22322 Twentieth Avenue

South East, Bothell, Washington 98021.

The financing is contemplated for

product development and working

capital.

The financing is brought within the

purview of Sec. 107.730(a)(1) of the

Regulations because TD Javelin I and its

associate, Tullis-Dickerson Capital

Focus II, LP, currently own greater than

10 percent of Prolinx, and therefore

Prolinx is considered an Associate of

each of TD Javelin I and TD Javelin II

as defined in Sec. 107.50 of the

regulations.

Notice is hereby given that any

interested person may submit written

comments on the transaction to the

Associate Administrator for Investment,

U.S. Small Business Administration,

409 Third Street, SW, Washington, DC

20416.

Dated: April 26, 2000.

Don A. Christensen,

Associate Administrator for Investment.

[FR Doc. 00–11498 Filed 5–8–00; 8:45 am]

BILLING CODE 8025–01–P

SMALL BUSINESS ADMINISTRATION

Notice Seeking Exemption Under

Section 312 of the Small Business

Investment Act, Conflicts of Interest

Notice is hereby given that TD Origen

Fund, L.P. (‘‘TD Origen’’), 150

Washington Avenue, Suite 201, Santa

Fe, New Mexico 87501, a Federal

Licensee under the Small Business

Investment Act of 1958, as amended

(‘‘the Act’’), TD Javelin Capital Fund, LP

(‘‘TD Javelin I’’), 2850 Cahaba Road,

Suite 240, Birmingham, Alabama 35223,

a Federal Licensee under the Act, and

TD Javelin Capital Fund II, LP (‘‘TD

Javelin II’’), 2850 Cahaba Road, Suite

240, Birmingham, Alabama 35223

(collectively ‘‘the Funds’’), in

connection with the financing of a small

concern, have sought an exemption

under section 312 of the Act and section

107.730, Financings which Constitute

Conflicts of Interest of the Small

Business Administration (‘‘SBA’’) rules

and regulations (13 CFR 107.730

(2000)). The Funds propose to provide

equity financing to Phase-1 Molecular

Toxicology, Inc. (‘‘Phase-1’’), 2904

Rodeo Park Drive East, Santa Fe, New

Mexico 97505. The financing is

contemplated for product development

and working capital.

The financing is brought within the

purview of Sec. 107.730(a)(1) of the